Published in J Virol Methods on June 01, 2005
High variety of known and new RNA and DNA viruses of diverse origins in untreated sewage. J Virol (2012) 2.03
Frequent detection of highly diverse variants of cardiovirus, cosavirus, bocavirus, and circovirus in sewage samples collected in the United States. J Clin Microbiol (2009) 1.68
Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination. Appl Environ Microbiol (2014) 1.00
Feasibility of quantitative environmental surveillance in poliovirus eradication strategies. Appl Environ Microbiol (2012) 0.95
Environmental surveillance of poliovirus and non-polio enterovirus in urban sewage in Dakar, Senegal (2007-2013). Pan Afr Med J (2014) 0.90
Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina. Appl Environ Microbiol (2009) 0.87
Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002. Appl Environ Microbiol (2007) 0.81
Environmental surveillance of human parechoviruses in sewage in The Netherlands. Appl Environ Microbiol (2013) 0.77
Detection of imported wild polioviruses and of vaccine-derived polioviruses by environmental surveillance in Egypt. Appl Environ Microbiol (2012) 0.76
The role of supplementary environmental surveillance to complement acute flaccid paralysis surveillance for wild poliovirus in Pakistan - 2011-2013. PLoS One (2017) 0.75
Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems. Food Environ Virol (2017) 0.75
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens. J Clin Microbiol (2006) 7.56
Enterovirus surveillance--United States, 1970-2005. MMWR Surveill Summ (2006) 4.78
Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol (2005) 4.42
From emergence to eradication: the epidemiology of poliomyelitis deconstructed. Am J Epidemiol (2010) 3.46
Genetic clustering of all 102 human rhinovirus prototype strains: serotype 87 is close to human enterovirus 70. J Gen Virol (2002) 3.30
Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand. Lancet (2005) 3.01
Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol (2004) 2.62
Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J Clin Virol (2003) 2.62
Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland. J Clin Virol (2010) 2.60
Vaccine policy changes and epidemiology of poliomyelitis in the United States. JAMA (2004) 2.60
Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol (2003) 2.51
Complete genome sequences of all members of the species Human enterovirus A. J Gen Virol (2004) 2.47
Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J Virol (2004) 2.44
Complete genomic sequencing shows that polioviruses and members of human enterovirus species C are closely related in the noncapsid coding region. J Virol (2003) 2.40
Enteroviruses 76, 89, 90 and 91 represent a novel group within the species Human enterovirus A. J Gen Virol (2005) 2.22
Fractional doses of inactivated poliovirus vaccine in Oman. N Engl J Med (2010) 2.21
Saffold virus, a human Theiler's-like cardiovirus, is ubiquitous and causes infection early in life. PLoS Pathog (2009) 2.15
Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol (2008) 2.10
Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial. Lancet Infect Dis (2011) 2.06
Species-specific RT-PCR amplification of human enteroviruses: a tool for rapid species identification of uncharacterized enteroviruses. J Gen Virol (2006) 2.04
Molecular identification and characterization of two proposed new enterovirus serotypes, EV74 and EV75. J Gen Virol (2004) 2.02
Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features. J Clin Microbiol (2002) 2.01
Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues. J Clin Microbiol (2009) 2.01
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ (2004) 1.90
Evolution of the genome of Human enterovirus B: incongruence between phylogenies of the VP1 and 3CD regions indicates frequent recombination within the species. J Gen Virol (2003) 1.89
Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis (2007) 1.76
Infant deaths associated with human parechovirus infection in Wisconsin. Clin Infect Dis (2010) 1.75
A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005. J Infect Dis (2008) 1.75
RNA recombination plays a major role in genomic change during circulation of coxsackie B viruses. J Virol (2004) 1.68
Resolving ambiguities in genetic typing of human enterovirus species C clinical isolates and identification of enterovirus 96, 99 and 102. J Gen Virol (2009) 1.67
Detection of all known parechoviruses by real-time PCR. J Clin Microbiol (2008) 1.61
Molecular phylogeny and proposed classification of the simian picornaviruses. J Virol (2002) 1.55
Vaccine-derived poliomyelitis 12 years after infection in Minnesota. N Engl J Med (2011) 1.54
Monovalent type 1 oral poliovirus vaccine in newborns. N Engl J Med (2008) 1.49
Molecular identification of 13 new enterovirus types, EV79-88, EV97, and EV100-101, members of the species Human Enterovirus B. Virus Res (2007) 1.48
Economic analysis of the global polio eradication initiative. Vaccine (2010) 1.47
An outbreak of concurrent echovirus 30 and coxsackievirus A1 infections associated with sea swimming among a group of travelers to Mexico. Clin Infect Dis (2008) 1.45
Phylogenetic analysis of human rhinovirus capsid protein VP1 and 2A protease coding sequences confirms shared genus-like relationships with human enteroviruses. J Gen Virol (2005) 1.44
Multiple independent emergences of type 2 vaccine-derived polioviruses during a large outbreak in northern Nigeria. J Virol (2013) 1.44
The minor receptor group of human rhinovirus (HRV) includes HRV23 and HRV25, but the presence of a lysine in the VP1 HI loop is not sufficient for receptor binding. J Virol (2005) 1.44
Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab Res Rev (2013) 1.43
Enterovirus surveillance reveals proposed new serotypes and provides new insight into enterovirus 5'-untranslated region evolution. J Gen Virol (2007) 1.38
Sequence analysis of human rhinoviruses in the RNA-dependent RNA polymerase coding region reveals large within-species variation. J Gen Virol (2004) 1.36
Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1. J Gen Virol (2003) 1.35
Eight years of experience with molecular identification of human enteroviruses. J Clin Microbiol (2008) 1.34
Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis (2008) 1.34
Enterovirus 94, a proposed new serotype in human enterovirus species D. J Gen Virol (2007) 1.33
Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis. J Med Virol (2010) 1.32
Characterization of a highly evolved vaccine-derived poliovirus type 3 isolated from sewage in Estonia. J Virol (2004) 1.29
Sequence and structure of human rhinoviruses reveal the basis of receptor discrimination. J Virol (2003) 1.29
Search for poliovirus carriers among people with primary immune deficiency diseases in the United States, Mexico, Brazil, and the United Kingdom. Bull World Health Organ (2004) 1.28
Possible eradication of wild poliovirus type 3--worldwide, 2012. MMWR Morb Mortal Wkly Rep (2014) 1.27
Genomic evidence that simian virus 2 and six other simian picornaviruses represent a new genus in Picornaviridae. Virology (2003) 1.27
Prolonged detection of indigenous wild polioviruses in sewage from communities in Egypt. Am J Epidemiol (2003) 1.26
Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future. J Virol (2003) 1.26
A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future. Am J Epidemiol (2005) 1.25
Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. J Virol (2003) 1.25
Characterizing the picornavirus landscape among synanthropic nonhuman primates in Bangladesh, 2007 to 2008. J Virol (2012) 1.23
Comparative genomic and functional analysis of 100 Lactobacillus rhamnosus strains and their comparison with strain GG. PLoS Genet (2013) 1.21
Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine. Appl Environ Microbiol (2008) 1.19
Transmission of imported vaccine-derived poliovirus in an undervaccinated community in Minnesota. J Infect Dis (2009) 1.18
Expert review on poliovirus immunity and transmission. Risk Anal (2012) 1.18
Randomized trial of type 1 and type 3 oral monovalent poliovirus vaccines in newborns in Africa. J Infect Dis (2011) 1.17
Structure of the Fab-labeled "breathing" state of native poliovirus. J Virol (2012) 1.16
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs. Risk Anal (2013) 1.16
Emergence of echovirus type 13 as a prominent enterovirus. Clin Infect Dis (2003) 1.13
In vitro antiviral activity of V-073 against polioviruses. Antimicrob Agents Chemother (2009) 1.13
Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media. J Med Virol (2004) 1.12
Parechovirus typing in clinical specimens by nested or semi-nested PCR coupled with sequencing. J Clin Virol (2010) 1.12
Alignment of capsid protein VP1 sequences of all human rhinovirus prototype strains: conserved motifs and functional domains. J Gen Virol (2006) 1.12
Surveillance systems to track progress toward global polio eradication - worldwide, 2012-2013. MMWR Morb Mortal Wkly Rep (2014) 1.11
Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal (2006) 1.10
Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs). Risk Anal (2013) 1.10
Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY). Diabetes Res Clin Pract (2003) 1.09
Progress toward polio eradication--Worldwide, 2013-2014. MMWR Morb Mortal Wkly Rep (2014) 1.09
What we are watching--five top global infectious disease threats, 2012: a perspective from CDC's Global Disease Detection Operations Center. Emerg Health Threats J (2013) 1.09